Top Markets
Coin of the day
Taiwan Bio Therapeutics Co., Ltd Taiwan Bio Therapeutics Co., Ltd

Taiwan Bio Therapeutics Co., Ltd

6892
Rank in Stocks #23260
Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative... Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative medicine, primarily dedicated to the development of novel cellular therapeutics. These advanced treatments are crafted to address a range of medical conditions, including degenerative disorders, cardiovascular ailments, complications stemming from diabetes, and autoimmune diseases. The company was established in 2014 and its operations are headquartered in Taipei City, Taiwan.
Share Price
$0.81087521
Last synced: 2026-08-21
Market Cap
$76.23M
Change (1 day)
0.39%
Change (1 year)
-26.90%
Country
TW
Trade Taiwan Bio Therapeutics Co., Ltd (6892)

Category

Operating Margin for Taiwan Bio Therapeutics Co., Ltd (6892)
Operating Margin as of 2026 TTM: 0.00%
According to Taiwan Bio Therapeutics Co., Ltd latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Taiwan Bio Therapeutics Co., Ltd from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.